Skip to main content

AptarGroup, Inc. (ATR) Stock Analysis

SellModerate Confidence

Healthcare · Medical Instruments & Supplies

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company... Read more

$125.49+10.2% upside
Score 5.0/10Target $138.55Reward/Risk 1.4:1

TrendMatrix rates AptarGroup, Inc. (ATR) as Sell with moderate confidence. The stock trades at $125.49 with +10.2% upside to the $138.55 price target. Overall score: 5.0/10 across 10 analysis dimensions. Reward/risk ratio: 1.4:1.

Passes 3/5 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.

Val5.9Qual5.0Grw3.0Mom1.1Sent8.6Ins3.2Peer5.4Tech6.3Risk7.95.0OVERALL

Investment Thesis

+ Strong earnings beat streak (4/4)
- Weak overall score: 5.0/10
- Weak growth
- Negative momentum

Fundamentals

P/E (TTM)21.1
P/E (Fwd)19.4
Mkt Cap$8.1B
EV/EBITDA11.4
Profit Mgn10.4%
ROE15.1%
Rev Growth13.5%
Beta0.44
Dividend1.50%
Analysts12
Frequently Asked Questions
Is ATR stock a buy right now?

TrendMatrix rates AptarGroup, Inc. (ATR) as Sell with moderate confidence. Score 5.0/10.

What is the ATR stock price target?

Take-profit target: $138.55 (+10.2% upside). Reward/risk ratio: 1.4:1. Stop-loss: $116.70.

What are the risks of investing in ATR?

Weak overall score: 5.0/10; Weak growth; Negative momentum.

Is ATR overvalued or undervalued?

AptarGroup, Inc. trades at a P/E of 21.1 (forward 19.4). TrendMatrix value score: 5.9/10. Verdict: Sell.

What do analysts say about ATR?

12 analysts cover ATR with a consensus score of 4.0/5. Average price target: $163.

What does AptarGroup, Inc. do?AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science...

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Related stocks: SOLV (Solventum Corporation) · RGEN (Repligen Corporation) · MMSI (Merit Medical Systems, Inc.) · STVN (Stevanato Group S.p.A.) · RMD (ResMed Inc.)
31 NEUTRAL
<20d<50d<200dDEATH CROSSSupp $120.31Res $144.01

Price Targets

$117
$139
Upside+10.2%
Reward/Risk1.4:1

Position Sizing

ConvictionNONE
Suggested %0.5%
Max %1%
RegimeCAUTIOUS

Risk Alerts

! MOMENTUM:1.1<5.0
! DEATH_CROSS:HARD_BLOCK
FALLING KNIFESuitability: Moderate
Risk/Reward 2.0>=2.0
Insider activity: OK
No SEC red flags
Momentum 1.1<5.0
Death cross (50MA < 200MA)